BiotechTube

Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live + Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck)

Phase 3Completed
0 watching 0 views this week📈 Rising
77
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Measles

Conditions

Measles, Mumps, Rubella, Varicella

Trial Timeline

Feb 1, 1999 → Jul 1, 2001

NCT ID
NCT00092391

About Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live + Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck)

Comparator: M-M-R(TM) II, measles, mumps, and rubella virus vaccine live + Comparator: VARIVAX(TM) Varicella Virus Vaccine Live (Oka-Merck) is a phase 3 stage product being developed by Merck for Measles. The current trial status is completed. This product is registered under clinical trial identifier NCT00092391. Target conditions include Measles, Mumps, Rubella.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00092391Phase 3Completed

Competing Products

20 competing products in Measles

See all competitors
ProductCompanyStageHype Score
Measles-Rubella vaccine (Live) I.P. (Freeze Dried) of M/s. Zydus Lifesciences Ltd + Yellow fever Vaccine (WHO prequalified)Zydus LifesciencesPhase 3
77
MMRV (AMP) + MMRV (2006 process)MerckPhase 3
77
M-M-R™II manufactured with recombinant Human Albumin (rHA) and VARIVAX®MerckPhase 3
77
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (ProQuad™) + M-M-R™ II and Varivax™MerckPhase 3
77
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: M-M-R II + Comparator: PUVVMerckPhase 2
52
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Varivax + Comparator: M-M-R IIMerckPhase 3
77
ProQuad® manufactured with recombinant Human Albumin (rHA)MerckPhase 3
77
measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine LiveMerckPhase 2
52
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Tripedia + Comparator: Comvax + Comparator: Varivax + Comparator: M-M-R IIMerckPhase 3
77
V221, measles, mumps, rubella and varicella (Oka/Merck) virus vaccine live / Duration of Treatment: 12 weeksMerckPhase 3
77
V205C, measles, mumps, and rubella virus vaccine live + Comparator: Measles, Mumps, and Rubella Virus Vaccine LiveMerckPhase 2
52
Comparator: ProQuad™ (V221) + Comparator: PREVNAR™ (pneumococcal 7-valent conjugate vaccine)MerckPhase 3
77
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live + Comparator: Placebo + Comparator: Varivax + Comparator: M-M-R IIMerckPhase 3
77
ProQuad®MerckPhase 3
77
MMR vaccineMerckPre-clinical
23
ProQuad®MerckPhase 3
77
ProQuad (Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live) + Comparator: M-M-R II + Comparator: Varivax + Comparator: PlaceboMerckPhase 3
77
Measles vaccineNovo NordiskApproved
84
Measles vaccineNovo NordiskApproved
84
Measles vaccineNovo NordiskApproved
84

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
Mavenclad®Approved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85